FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.4-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

771593009: Interleukin 23 receptor antagonist (disposition)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2019. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
3706927014 Interleukin 23 receptor antagonist (disposition) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
3706928016 Interleukin 23 receptor antagonist en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3706927014 Interleukin 23 receptor antagonist (disposition) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
3706928016 Interleukin 23 receptor antagonist en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Interleukin 23 receptor antagonist (disposition) Is a Interleukin receptor antagonist (disposition) true Inferred relationship Existential restriction modifier (core metadata concept)
Inbound Relationships Type Active Source Characteristic Refinability Group
Tildrakizumab (substance) Has disposition True Interleukin 23 receptor antagonist (disposition) Inferred relationship Existential restriction modifier (core metadata concept)
Substance with interleukin 23 receptor antagonist mechanism of action (substance) Has disposition True Interleukin 23 receptor antagonist (disposition) Inferred relationship Existential restriction modifier (core metadata concept)
Risankizumab Has disposition True Interleukin 23 receptor antagonist (disposition) Inferred relationship Existential restriction modifier (core metadata concept)
Mirikizumab (substance) Has disposition True Interleukin 23 receptor antagonist (disposition) Inferred relationship Existential restriction modifier (core metadata concept)
Ustekinumab Has disposition True Interleukin 23 receptor antagonist (disposition) Inferred relationship Existential restriction modifier (core metadata concept)
Guselkumab (substance) Has disposition True Interleukin 23 receptor antagonist (disposition) Inferred relationship Existential restriction modifier (core metadata concept)

This concept is not in any reference sets

Back to Start